Mitsubishi UFJ Trust & Banking
MRNA icon

Mitsubishi UFJ Trust & Banking’s Moderna MRNA Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Sell
44,306
-296,596
-87% -$15.3M 0.01% 670
2026
Q1 		$17.3M Buy
340,902
+196,619
+136% +$9.17M 0.04% 361
2025
Q4 		$4.25M Buy
144,283
+53,273
+59% +$1.45M 0.01% 685
2025
Q3 		$2.35M Buy
+91,010
New +$2.54M 0.01% 780
2025
Q2 		– Sell
-236,752
Closed -$6.71M – 1095
2025
Q1 		$6.71M Sell
236,752
-383,419
-62% -$13.6M 0.02% 631
2024
Q4 		$25.8M Sell
620,171
-26,060
-4% -$1.25M 0.06% 317
2024
Q3 		$43.2M Sell
646,231
-29,696
-4% -$2.73M 0.1% 219
2024
Q2 		$80.3M Sell
675,927
-88,049
-12% -$11.1M 0.19% 111
2024
Q1 		$81.4M Sell
763,976
-79,656
-9% -$8.03M 0.19% 124
2023
Q4 		$83.9M Sell
843,632
-67,536
-7% -$5.68M 0.2% 122
2023
Q3 		$94.1M Sell
911,168
-79,745
-8% -$8.9M 0.24% 100
2023
Q2 		$120M Sell
990,913
-96,376
-9% -$12.9M 0.28% 83
2023
Q1 		$167M Buy
1,087,289
+19,772
+2% +$3.26M 0.41% 52
2022
Q4 		$192M Sell
1,067,517
-71,705
-6% -$11.7M 0.5% 41
2022
Q3 		$135M Buy
1,139,222
+33,133
+3% +$5.03M 0.38% 57
2022
Q2 		$158M Buy
1,106,089
+3,345
+0.3% +$478K 0.4% 55
2022
Q1 		$190M Buy
1,102,744
+65,184
+6% +$11M 0.43% 47
2021
Q4 		$264M Sell
1,037,560
-127
-0% -$37.1K 0.54% 33
2021
Q3 		$399M Sell
1,037,687
-65,397
-6% -$24.1M 0.86% 14
2021
Q2 		$259M Sell
1,103,084
-156,310
-12% -$27.9M 0.55% 29
2021
Q1 		$165M Buy
1,259,394
+136,822
+12% +$19.8M 0.36% 61
2020
Q4 		$117M Buy
1,122,572
+520,312
+86% +$52.6M 0.24% 102
2020
Q3 		$42.6M Sell
602,260
-19,553
-3% -$1.36M 0.1% 236
2020
Q2 		$39.9M Buy
621,813
+202,003
+48% +$11.1M 0.1% 230
2020
Q1 		$12.6M Buy
419,810
+720
+0.2% +$16.6K 0.04% 428
2019
Q4 		$8.2M Sell
419,090
-7,750
-2% -$137K 0.02% 640
2019
Q3 		$6.79M Sell
426,840
-9,120
-2% -$135K 0.02% 661
2019
Q2 		$6.38M Buy
435,960
+2,950
+0.7% +$63.4K 0.02% 623
2019
Q1 		$8.81M Buy
+433,010
New +$8.04M 0.03% 528

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's MRNA Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking reduced its Moderna (MRNA) stake by 87% in Q2 2026, selling an estimated $15.3M and leaving 44,306 shares worth $3.1M. The position accounts for 0.01% of the portfolio, ranked #670.

Mitsubishi UFJ Trust & Banking first reported a position in MRNA in Q1 2019 and has held it in 29 quarters since. The position peaked at $399M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 44,306 shares of Moderna worth $3.1M as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking sold 296,596 Moderna shares in Q2 2026, an estimated $15.3M.
  • Moderna made up 0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #670 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Moderna in Q1 2019 and has held it in 29 quarters since.
  • Mitsubishi UFJ Trust & Banking's Moderna position peaked at $399M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.